MARTINSRIED, Germany, Dec. 3, 2007 (PRIME NEWSWIRE) -- MorphoSys AG (Frankfurt:MOR.F - News) (Prime Standard Segment) yesterday announced the formation of one of the most comprehensive strategic alliances in the discovery and development of biopharmaceuticals with Novartis. The deal is aimed at establishing a pipeline of innovative drugs, and combines MorphoSys’s and Novartis’s research, development, manufacturing and commercialization capabilities.
